Labeler
Shorla Oncology Inc. NDC Codes
Shorla Oncology Inc. lists 6 finished drug products in the FDA NDC Directory under NDC labeler code 81927.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- nelarabine, Tepylute, Imkeldi, Jylamvo
- Active ingredients
- Nelarabine, Thiotepa, Imatinib mesylate, Methotrexate
- NDC labeler codes
- 81927
- Strengths
- Nelarabine 5 mg/mL; Thiotepa 10 mg/mL; Imatinib mesylate 80 mg/mL; Methotrexate 2 mg/mL
- Dosage forms
- Injection, Solution
- Routes
- Intravenous, Oral
- Drug classes (FDA established)
- Nucleoside Metabolic Inhibitor, Alkylating Drug, Kinase Inhibitor, Folate Analog Metabolic Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 7
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| nelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 81927-375 | 81927-0375-01 | — |
| Tepylutethiotepa | Thiotepa 10 mg/mL | InjectionIntravenous | 81927-105 | 81927-0105-01 | — |
| Tepylutethiotepa | Thiotepa 10 mg/mL | InjectionIntravenous | 81927-106 | 81927-0106-01 | — |
| Imkeldiimatinib oral | Imatinib mesylate 80 mg/mL | SolutionOral | 81927-201 | 81927-0201-01 | — |
| Jylamvomethotrexate | Methotrexate 2 mg/mL | SolutionOral | 81927-204 | 81927-0204-01 | — |
| nelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 81927-111 | 81927-0111-0181927-0111-06 | — |
Shorla Oncology Inc.: common questions
- What is Shorla Oncology Inc.'s NDC labeler code?
- 81927. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Shorla Oncology Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.